Lv1
40 积分 2024-04-25 加入
Νοvel Therapies in High‐Risk Myelodysplastic Syndromes
4个月前
已完结
Refined risk stratification helps guiding transplantation choice in adult BCR::ABL1-positive acute lymphoblastic leukemia
4个月前
已关闭
Mitochondrial dysfunction fuels drug resistance in adult T-cell acute lymphoblastic leukemia
4个月前
已关闭
PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion
4个月前
已完结
Molecular mechanisms of unique therapeutic potential of CUDC-907 for MEF2D fusion-driven BCP-ALL
4个月前
已关闭
Strategies to Enhance CAR ‐T Cell Persistence in Hematologic Malignancies: From Molecular Design to Clinical Optimization
5个月前
已完结
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial
8个月前
已完结
Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)
11个月前
已完结
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial
11个月前
已完结
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
11个月前
已完结
皖公网安备34019202002308
